Radium-223 dichloride
Approved Use: Indicated for the treatment of patients with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastatic disease
Dose: 1.49 µCi/kg, given at 4 week intervals for 6 injections (*revised March, 2016*)
Brand Name: Xofigo®
Manufacturer: Bayer
Package Insert
How Supplied: 178 µCi vial
Volume: 6 mL
Calibration and Production Schedule: Call Xofigo Access Services 1-855-696-3446
Expiration: 28 days after calibration
NDC #: 50419-208-01
Product Website
Ordering Guide (dispensed through Cardinal Health)
Letter from Manufacturer March 2016 (NIST revisions and corresponding label change)
Clinical Guidelines:
ACR–ACNM–ASTRO–SNMMI Practice Parameter for the Performance of Therapy with Radium-223 (2019)
Dose: 1.49 µCi/kg, given at 4 week intervals for 6 injections (*revised March, 2016*)
Brand Name: Xofigo®
Manufacturer: Bayer
Package Insert
How Supplied: 178 µCi vial
Volume: 6 mL
Calibration and Production Schedule: Call Xofigo Access Services 1-855-696-3446
Expiration: 28 days after calibration
NDC #: 50419-208-01
Product Website
Ordering Guide (dispensed through Cardinal Health)
Letter from Manufacturer March 2016 (NIST revisions and corresponding label change)
Clinical Guidelines:
ACR–ACNM–ASTRO–SNMMI Practice Parameter for the Performance of Therapy with Radium-223 (2019)